WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke AMGEN wurde als Wortmarke am 09.02.2006 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 893256 |
| Länder | 
|
| Basismarke |
Nr. ,
01. Juli 2024
|
| Anmeldedatum | 09. Februar 2006 |
| Ablaufdatum | 09. Februar 2026 |
Markeninhaber
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
US
Thousand Oaks, CA 91320-1799
US
Markenvertreter
444 West Lake Street, Suite 4000
Chicago Illinois 60606-0029
US
Waren und Dienstleistungen
05
Pharmaceutical preparations, namely, erythropoietin for use
in treating chronic anemia, granulocyte colony stimulation
factor, granulocyte-macrophage colony stimulating factor for
use in restoring the level of white blood cells, hepatitis B
vaccine, interferon and interleukin 2 for use in anticancer
and antiviral applications, epidermal growth factor and
platelet-derived growth factor for use in treating surgical
or soft tissue damage; a full line of pharmaceuticals, and
pharmaceuticals, including human recombinant erythropoietin
and erythropoiesis stimulating protein; pharmaceuticals for
use in stimulating production of red blood cells, white
blood cells or platelets; pharmaceuticals for modulating
calcium, phosphorus, or parathyroid hormone levels in the
blood or for treatment of hyperparathyroidism, hypercalcemia
or bone metabolism related disorders and diseases;
pharmaceuticals for treating human immune diseases and
conditions; pharmaceuticals for the treatment of viral
infections, neoplastic, metabolic, autoimmune or
inflammatory disorders; pharmaceuticals for the treatment of
injury to epithelial cells and tissues; pharmaceuticals for
modulating weight loss, regulating reproductive function and
promoting wound healing, and for use in the treatment of
obesity, diabetes, hypertension, dyslipidemia and
cardiovascular diseases and infertility; support kits for
patients afflicted with autoimmune or inflammatory
disorders, comprised primarily of materials for wound
dressing and sterilization; one or more of the
aforementioned pharmaceutical preparations sold in prefilled
syringes
10
Medical apparatus, namely a reusable device which assists in
removing needle guards and adds stability to delivery of
drugs by syringe and a reusable spring-loaded medical
syringe holder for facilitating delivery of drugs by
syringe; injectors for medical purposes; device for delivery
of a drug
42
Genetic engineering research and development services for
others; medical research namely, clinical trial services
44
Information services, namely providing information of
interest to cancer patients; information services relating
to medical services via a global computer network
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 09. Februar 2016 | 2016/7 Gaz | Verlängerung | |
| 24. Juni 2011 | 2012/4 Gaz | US | RAW: Partial Ceasing Effect |
| 18. Juni 2008 | 2008/28 Gaz | TR | RAW: Protection Granted |
| 25. September 2007 | 2007/41 Gaz | GE | RAW: Protection Granted |
| 09. Februar 2006 | 2006/35 Gaz | US | Eintragung |
| Teilweise Löschung |
ID: 14893256